A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure
Sébert, Marie, Renneville, Aline, Bally, Cécile, Peterlin, Pierre, Beyne-Rauzy, Odile, Legros, Laurence, Gourin, Marie-Pierre, Sanhes, Laurence, Wattel, Eric, Gyan, Emmanuel, Park, Sophie, StamatoullaЖурнал:
Haematologica
DOI:
10.3324/haematol.2018.207118
Date:
February, 2019
Файл:
PDF, 4.96 MB
2019
File converter
Більше результатів пошуку
More benefits 
